BioSpace News Archive

Business

AveXis to Report Third Quarter 2017 Financial and Operating Results

Conference call and webcast will be on November 9 at 4:30 p.m. ET.

November 2, 2017

·

2 min read

Genetown

Synspira Announces Data for Lead Candidate at the 31st Annual North American Cystic Fibrosis Conference

The studies were led by the laboratory of Steven M. Rowe M.D. at the University of Alabama at Birmingham and will be presented at the 31st Annual North American Cystic Fibrosis Conference (NACFC), being held from November 2-4, 2017 in Indianapolis, IN.

November 2, 2017

·

5 min read

BioPorto: Private Placement Fully Subscribed

The board decided on October 27, 2017 to partially exercise the authorization in article 16b of the Company’s Articles of Association to issue up to 13,015,625 new shares in a private placement to a limited number of investors.

November 2, 2017

·

2 min read

Genetown

Five-Year Follow-Up Data Demonstrate the WATCHMAN™ Left Atrial Appendage Closure Device Provides Stroke Risk Reduction Comparable to Warfarin Therapy

The PREVAIL data, combined with final five-year outcomes from the PROTECT-AF clinical trial, demonstrated the WATCHMAN device continues to be a safe and effective alternative to long-term warfarin therapy offering comparable stroke risk reduction for patients with non-valvular atrial fibrillation.

November 2, 2017

·

5 min read

Biotech Beach

Arcturus Therapeutics to Host Key Opinion Leader Call on Advances in Delivery of Nucleic Acid Medicines on Tuesday, November 7

One of the featured speakers on the webcast will be Pad Chivukula, Ph.D., Arcturus’s CSO and COO.

November 2, 2017

·

6 min read

Business

NewLink Genetics Reports Third Quarter 2017 Financial Results and Updates Indoximod Program

Management will host a conference call today at 8:30 a.m. ET.

November 2, 2017

·

9 min read

Policy

Progenics Completes Submission of NDA for AZEDRA (iobenguane I 131) in Pheochromocytoma and Paraganglioma

AZEDRA has received Breakthrough Therapy, Orphan Drug and Fast Track designations from the FDA.

November 2, 2017

·

5 min read

Pharm Country

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

The stock options and restricted stock units were granted as inducements material to the new employees becoming employees of Aclaris in accordance with NASDAQ Listing Rule 5635(c)(4).

November 2, 2017

·

2 min read

Policy

KemPharm’s KP484 for the Treatment of ADHD, An Investigational Prodrug of Methylphenidate, Allowed to Proceed to Clinical Studies

The company may proceed with its planned clinical investigation for the treatment of attention deficit hyperactivity disorder.

November 2, 2017

·

5 min read

Business

Cerveau Technologies and Sinotau Pharmaceutical Group Announce Sinotau’s Achievement of a Major Milestone in China Strategy

Sinotau Pharmaceuticals has announced today an agreement with HTA CO. LTD for launching a new β-amyloid imaging agent for Alzheimer’s disease in China.

November 2, 2017

·

2 min read